Abstract
ObjectivesTo evaluate long-term clinical/radiographic efficacy of subcutaneous UST 45/90 mg in patients with active psoriatic arthritis (PsA) through wk108 of the PSUMMIT 1 trial.MethodsAdult PsA pts (n=615) with active disease...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have